Search Results
132 items found for "chronic kidney disease"
- Ep 107 with Dr. Roger Sunahara
studies to address the functional role of these dramatic conformational changes and the relationship to disease continues to engineer the enzyme to optimize its potential as a treatment for cocaine abuse, a debilitating disease
- Ep 101 with Dr Caron Tribute Part 2
neurotransmitters and how they might underlie brain and behavior disorders such as schizophrenia, Parkinson's disease
- Ep 141 with Dr Tobi Langenhan
physiological and pharmacological principles that underlie the workings of adhesion GPCRs in health and disease
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
development of new therapeutic interventions for the alleviation of L-DOPA-induced dyskinesia in Parkinson’s Disease
- Ep 100 with Dr Caron Tribute Part 1
neurotransmitters and how they might underlie brain and behavior disorders such as schizophrenia, Parkinson's disease
- Ep 18 with Dr. Yamina Berchiche
and pharmacology can provide new opportunities to improve our understanding of human physiology and disease
- Ep 84 with Rosie Dawaliby
Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases
- Ep 92 with Dr. Stephane Angers
of growth factors and their signaling mechanisms in development, adult tissue homeostasis, and human diseases
- Chemokine N-terminal-derived peptides differentially regulate signaling by the receptors CCR1 and CCR5
CCR1 and CCR5 Published date November 23, 2023 Abstract "Inflammatory chemokines are often elevated in disease
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis
Colorectal cancer (CRC) is a prevalent malignant tumor worldwide, leading to significant morbidity and disease
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases
- Ep 102 with Dr Caron Tribute Part 3
neurotransmitters and how they might underlie brain and behavior disorders such as schizophrenia, Parkinson's disease
- Chemoattractant receptor signaling in humoral immunity
humoral immunity and discuss the potential of the COMMD3/8 complex as a therapeutic target for autoimmune diseases
- A GPCR-neuropeptide axis dampens hyperactive neutrophils by promoting an alternative-like polarization during bacterial infection
expressed NPFF, these findings could have broad implications in various infectious and inflammatory diseases
- GPCR Retreat 2023 - Part I
laboratory has gained valuable insights into the genetic basis and pathophysiology of lymphatic vascular disease , preeclampsia and sex-dependent cardiovascular disease.
- Atypical Structure and Function of Typical Chemokine Receptors
Our laboratory is working to help patients by developing genetically-modified mice that have disease-causing
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
small molecules can selectively disable noncanonical mechanisms of G-protein activation dysregulated in disease
- Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer
second area of interest has been the elucidation of the molecular basis for a rare autosomal human disease
- Structural Basis for the Recognition of GPRC5D by Talquetamab, a Bispecific Antibody for Multiple Myeloma
Despite advances in the treatment, many patients experience disease relapse or become refractory to treatment
- Interaction with the cell adhesion molecule NEGR1 affects mGluR5 cell signalling
were shown to be very effective to rescue the cell death observed in a mouse model of Huntington’s disease
- Ep 132 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Ep 42 with Dr. Randy Hall
Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb
- Ep 130 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Ep 133 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- Ep 131 with Dr. Richard Premont
where he remained until 2018 studying GPCRs and their signaling pathways in the liver and in liver disease
- GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis
Exosomes transport a variety of macromolecules and modulate intercellular communication in physiology and disease
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
essential in regulating GPCR signaling, and most members are implicated as critical nodes in human diseases
- Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer
cancer Published date June 24, 2024 Abstract "Pancreatic ductal adenocarcinoma (PDAC) remains a dreadful disease